All Speakers (na, Swaziland)
Author Of 35 Presentations
Lessons from real world data (ID 26)
Q&A (ID 425)
Lecture Time
10:45 - 10:45
Speakers
Authors
Session Name
Room
Munich Hall
Date
Thu, 05.05.2022
Time
10:45 - 12:15
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (ID 41)
Discussion led by the Chairs (ID 350)
Lecture Time
11:05 - 11:25
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Wed, 04.05.2022
Time
10:45 - 11:25
AstraZeneca - Controversies in Breast Cancer (ID 48)
Q&A / discussion (ID 478)
Lecture Time
12:15 - 12:30
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
EONS - Supportive care issues in breast cancer (ID 11)
Q&A and discussion (ID 277)
Lecture Time
14:45 - 14:45
Speakers
Authors
Room
Cologne Hall
Date
Wed, 04.05.2022
Time
14:45 - 16:15
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Optimizing the Use of CDK4/6 Inhibitors as Adjuvant Therapy in HR-positive, HER2-negative Early Breast Cancer: A Focus on Patient Management (ID 439)
Lecture Time
12:30 - 12:30
Speakers
Authors
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30
Challenges and landscape of emerging approaches in metastatic triple negative breast cancer (mTNBC) (ID 39)
Q&A (ID 389)
Lecture Time
15:05 - 15:05
Speakers
Authors
Session Name
Room
Frankfurt Hall
Date
Wed, 04.05.2022
Time
14:45 - 16:15
Immunotherapy of metastatic breast cancer: Where do we stand? (ID 23)
Q&A (ID 321)
Lecture Time
17:35 - 17:45
Speakers
Authors
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
16:15 - 17:45
YOC boxing session (ID 45)
Q&A and discussion (ID 456)
Lecture Time
17:35 - 17:45
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
16:45 - 17:45
Adjuvant treatment luminal in breast cancer (ID 38)
Q&A (ID 430)
Lecture Time
10:45 - 10:45
Speakers
Authors
Session Name
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
10:45 - 12:15
Oligometastatic diseases (OMD) (ID 43)
Q&A (ID 355)
Lecture Time
10:45 - 10:45
Speakers
Authors
Session Name
Room
Hamburg Hall
Date
Wed, 04.05.2022
Time
10:45 - 12:15
Proffered Paper session 2 (ID 8)
Q&A and discussion (ID 284)
Lecture Time
18:00 - 18:15
Speakers
Authors
Session Name
Room
Berlin Hall
Date
Wed, 04.05.2022
Time
16:45 - 18:15
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Questions and Take-Home Learnings (ID 440)
Lecture Time
12:30 - 12:30
Speakers
Authors
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30
Antibody drug conjugates (ADCs) to treat breast cancer (ID 34)
Q&A (ID 394)
Lecture Time
14:45 - 14:45
Speakers
Authors
Room
Munich Hall
Date
Wed, 04.05.2022
Time
14:45 - 16:15
ESMO Colloquium supported by Lilly - Optimising risk prediction, management and compliance for patients with early HR+ HER2- breast cancer: The start of a journey (ID 33)
Q&A and discussion (ID 333)
Lecture Time
19:15 - 19:30
Speakers
Authors
Room
Munich Hall
Date
Tue, 03.05.2022
Time
18:00 - 19:35
Mini Oral session 1 (ID 6)
Q&A and discussion (ID 457)
Lecture Time
16:53 - 17:08
Speakers
Authors
Session Name
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
16:15 - 17:30
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Predicting Risk of Recurrence in HR-positive, HER2-negative Early Breast Cancer: A Focus on Clinicopathological Factors (ID 436)
Lecture Time
12:30 - 12:30
Speakers
Authors
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30
Treatment strategies for HER2+ metastatic breast cancer (mBC) (ID 15)
Q&A (ID 365)
Lecture Time
12:05 - 12:15
Speakers
Authors
Room
Munich Hall
Date
Wed, 04.05.2022
Time
10:45 - 12:15
Mini Oral session 3 (ID 10)
Q&A and discussion (ID 300)
Lecture Time
11:23 - 11:35
Speakers
Authors
Session Name
Room
Frankfurt Hall
Date
Thu, 05.05.2022
Time
10:45 - 11:45
Risk based prevention and screening in breast cancer (ID 31)
Q&A (ID 445)
Lecture Time
13:45 - 13:45
Speakers
Authors
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
13:45 - 15:15
Emerging new drugs and strategies for breast cancer (ID 25)
Q&A (ID 407)
Lecture Time
10:05 - 10:20
Speakers
Authors
Room
Frankfurt Hall
Date
Thu, 05.05.2022
Time
08:45 - 10:15
Genetic testing and implications in early breast cancer (eBC) patients (ID 19)
Q&A (ID 339)
Lecture Time
08:45 - 08:45
Speakers
Authors
Room
Frankfurt Hall
Date
Wed, 04.05.2022
Time
08:45 - 10:15
Special session on the Ukraine: How many wars to fight? (ID 46)
Q&A and discussion (ID 472)
Lecture Time
12:15 - 12:20
Speakers
Authors
Room
Cologne Hall
Date
Wed, 04.05.2022
Time
11:35 - 12:20
Mini Oral session 1 (ID 6)
Q&A and discussion (ID 10)
Lecture Time
17:22 - 17:32
Speakers
Authors
Session Name
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
16:15 - 17:30
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Tools to Guide Risk Assessment and Adjuvant Treatment Decisions in HR-positive, HER2-negative Early Breast Cancer: A Focus on Best Practices (ID 437)
Lecture Time
12:30 - 12:30
Speakers
Authors
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30
Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice (ID 30)
Q&A (ID 372)
Lecture Time
13:10 - 13:20
Speakers
Authors
Session Name
Room
Munich Hall
Date
Wed, 04.05.2022
Time
13:00 - 14:00
Proffered Paper session 1 (ID 12)
Q&A and discussion (ID 309)
Lecture Time
15:05 - 15:15
Speakers
Authors
Session Name
Room
Munich Hall
Date
Tue, 03.05.2022
Time
13:45 - 15:15
Neo-adjuvant and adjuvant triple negative breast cancer (TNBC) (ID 27)
Q&A (ID 450)
Lecture Time
14:05 - 14:05
Speakers
Authors
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
13:45 - 15:15
Treating HER2 low metastatic breast cancer (ID 36)
Q&A (ID 416)
Lecture Time
10:05 - 10:15
Speakers
Authors
Session Name
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
08:45 - 10:15
EONS - Taking care of disadvantaged people with breast cancer: What’s the evidence? (ID 18)
Q&A and discussion (ID 344)
Lecture Time
08:45 - 08:45
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Wed, 04.05.2022
Time
08:45 - 10:15
José Baselga: Cancer’s fiercest opponent (ID 49)
Documentary (ID 476)
Lecture Time
10:08 - 11:05
Speakers
Authors
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
Mini Oral session 2 (ID 2)
Q&A and discussion (ID 17)
Lecture Time
09:38 - 09:50
Speakers
Authors
Session Name
Room
Hamburg Hall
Date
Wed, 04.05.2022
Time
09:00 - 10:00
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Impact of CDK4/6 Inhibitors as Adjuvant Therapy in HR-positive, HER2-negative Early Breast Cancer: A Focus on Recent Evidence (ID 438)
Lecture Time
12:30 - 12:30
Speakers
Authors
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30
Tailoring treatment for early HER2 breast cancer (ID 32)
Q&A (ID 384)
Lecture Time
14:45 - 14:45
Speakers
Authors
Room
Hamburg Hall
Date
Wed, 04.05.2022
Time
14:45 - 16:15
How to collect and use PRO data in clinical settings (ID 42)
Q&A (ID 316)
Lecture Time
16:15 - 16:15
Speakers
Authors
Room
Munich Hall
Date
Tue, 03.05.2022
Time
16:15 - 17:45
YOC boxing session (ID 45)
Q&A and discussion (ID 455)
Lecture Time
17:05 - 17:15
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
16:45 - 17:45
Presenter Of 35 Presentations
Neo-adjuvant and adjuvant triple negative breast cancer (TNBC) (ID 27)
Q&A (ID 450)
Lecture Time
14:05 - 14:05
Speakers
Authors
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
13:45 - 15:15
Treating HER2 low metastatic breast cancer (ID 36)
Q&A (ID 416)
Lecture Time
10:05 - 10:15
Speakers
Authors
Session Name
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
08:45 - 10:15
EONS - Taking care of disadvantaged people with breast cancer: What’s the evidence? (ID 18)
Q&A and discussion (ID 344)
Lecture Time
08:45 - 08:45
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Wed, 04.05.2022
Time
08:45 - 10:15
José Baselga: Cancer’s fiercest opponent (ID 49)
Documentary (ID 476)
Lecture Time
10:08 - 11:05
Speakers
Authors
Session Name
Room
Berlin Hall
Date
Tue, 03.05.2022
Time
10:00 - 11:20
Mini Oral session 2 (ID 2)
Q&A and discussion (ID 17)
Lecture Time
09:38 - 09:50
Speakers
Authors
Session Name
Room
Hamburg Hall
Date
Wed, 04.05.2022
Time
09:00 - 10:00
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Impact of CDK4/6 Inhibitors as Adjuvant Therapy in HR-positive, HER2-negative Early Breast Cancer: A Focus on Recent Evidence (ID 438)
Lecture Time
12:30 - 12:30
Speakers
Authors
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30
Tailoring treatment for early HER2 breast cancer (ID 32)
Q&A (ID 384)
Lecture Time
14:45 - 14:45
Speakers
Authors
Room
Hamburg Hall
Date
Wed, 04.05.2022
Time
14:45 - 16:15
How to collect and use PRO data in clinical settings (ID 42)
Q&A (ID 316)
Lecture Time
16:15 - 16:15
Speakers
Authors
Room
Munich Hall
Date
Tue, 03.05.2022
Time
16:15 - 17:45
YOC boxing session (ID 45)
Q&A and discussion (ID 455)
Lecture Time
17:05 - 17:15
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
16:45 - 17:45
Lessons from real world data (ID 26)
Q&A (ID 425)
Lecture Time
10:45 - 10:45
Speakers
Authors
Session Name
Room
Munich Hall
Date
Thu, 05.05.2022
Time
10:45 - 12:15
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (ID 41)
Discussion led by the Chairs (ID 350)
Lecture Time
11:05 - 11:25
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Wed, 04.05.2022
Time
10:45 - 11:25
AstraZeneca - Controversies in Breast Cancer (ID 48)
Q&A / discussion (ID 478)
Lecture Time
12:15 - 12:30
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
11:30 - 12:30
EONS - Supportive care issues in breast cancer (ID 11)
Q&A and discussion (ID 277)
Lecture Time
14:45 - 14:45
Speakers
Authors
Room
Cologne Hall
Date
Wed, 04.05.2022
Time
14:45 - 16:15
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Optimizing the Use of CDK4/6 Inhibitors as Adjuvant Therapy in HR-positive, HER2-negative Early Breast Cancer: A Focus on Patient Management (ID 439)
Lecture Time
12:30 - 12:30
Speakers
Authors
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30
Challenges and landscape of emerging approaches in metastatic triple negative breast cancer (mTNBC) (ID 39)
Q&A (ID 389)
Lecture Time
15:05 - 15:05
Speakers
Authors
Session Name
Room
Frankfurt Hall
Date
Wed, 04.05.2022
Time
14:45 - 16:15
Immunotherapy of metastatic breast cancer: Where do we stand? (ID 23)
Q&A (ID 321)
Lecture Time
17:35 - 17:45
Speakers
Authors
Room
Hamburg Hall
Date
Tue, 03.05.2022
Time
16:15 - 17:45
YOC boxing session (ID 45)
Q&A and discussion (ID 456)
Lecture Time
17:35 - 17:45
Speakers
Authors
Session Name
Room
Cologne Hall
Date
Tue, 03.05.2022
Time
16:45 - 17:45
Adjuvant treatment luminal in breast cancer (ID 38)
Q&A (ID 430)
Lecture Time
10:45 - 10:45
Speakers
Authors
Session Name
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
10:45 - 12:15
Oligometastatic diseases (OMD) (ID 43)
Q&A (ID 355)
Lecture Time
10:45 - 10:45
Speakers
Authors
Session Name
Room
Hamburg Hall
Date
Wed, 04.05.2022
Time
10:45 - 12:15
Proffered Paper session 2 (ID 8)
Q&A and discussion (ID 284)
Lecture Time
18:00 - 18:15
Speakers
Authors
Session Name
Room
Berlin Hall
Date
Wed, 04.05.2022
Time
16:45 - 18:15
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Questions and Take-Home Learnings (ID 440)
Lecture Time
12:30 - 12:30
Speakers
Authors
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30
Antibody drug conjugates (ADCs) to treat breast cancer (ID 34)
Q&A (ID 394)
Lecture Time
14:45 - 14:45
Speakers
Authors
Room
Munich Hall
Date
Wed, 04.05.2022
Time
14:45 - 16:15
ESMO Colloquium supported by Lilly - Optimising risk prediction, management and compliance for patients with early HR+ HER2- breast cancer: The start of a journey (ID 33)
Q&A and discussion (ID 333)
Lecture Time
19:15 - 19:30
Speakers
Authors
Room
Munich Hall
Date
Tue, 03.05.2022
Time
18:00 - 19:35
Mini Oral session 1 (ID 6)
Q&A and discussion (ID 457)
Lecture Time
16:53 - 17:08
Speakers
Authors
Session Name
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
16:15 - 17:30
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Predicting Risk of Recurrence in HR-positive, HER2-negative Early Breast Cancer: A Focus on Clinicopathological Factors (ID 436)
Lecture Time
12:30 - 12:30
Speakers
Authors
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30
Treatment strategies for HER2+ metastatic breast cancer (mBC) (ID 15)
Q&A (ID 365)
Lecture Time
12:05 - 12:15
Speakers
Authors
Room
Munich Hall
Date
Wed, 04.05.2022
Time
10:45 - 12:15
Mini Oral session 3 (ID 10)
Q&A and discussion (ID 300)
Lecture Time
11:23 - 11:35
Speakers
Authors
Session Name
Room
Frankfurt Hall
Date
Thu, 05.05.2022
Time
10:45 - 11:45
Risk based prevention and screening in breast cancer (ID 31)
Q&A (ID 445)
Lecture Time
13:45 - 13:45
Speakers
Authors
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
13:45 - 15:15
Emerging new drugs and strategies for breast cancer (ID 25)
Q&A (ID 407)
Lecture Time
10:05 - 10:20
Speakers
Authors
Room
Frankfurt Hall
Date
Thu, 05.05.2022
Time
08:45 - 10:15
Genetic testing and implications in early breast cancer (eBC) patients (ID 19)
Q&A (ID 339)
Lecture Time
08:45 - 08:45
Speakers
Authors
Room
Frankfurt Hall
Date
Wed, 04.05.2022
Time
08:45 - 10:15
Special session on the Ukraine: How many wars to fight? (ID 46)
Q&A and discussion (ID 472)
Lecture Time
12:15 - 12:20
Speakers
Authors
Room
Cologne Hall
Date
Wed, 04.05.2022
Time
11:35 - 12:20
Mini Oral session 1 (ID 6)
Q&A and discussion (ID 10)
Lecture Time
17:22 - 17:32
Speakers
Authors
Session Name
Room
Frankfurt Hall
Date
Tue, 03.05.2022
Time
16:15 - 17:30
AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)
Tools to Guide Risk Assessment and Adjuvant Treatment Decisions in HR-positive, HER2-negative Early Breast Cancer: A Focus on Best Practices (ID 437)
Lecture Time
12:30 - 12:30
Speakers
Authors
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30
Seagen - Treatment sequencing in HER2-positive metastatic breast cancer: from guidelines to clinical practice (ID 30)
Q&A (ID 372)
Lecture Time
13:10 - 13:20
Speakers
Authors
Session Name
Room
Munich Hall
Date
Wed, 04.05.2022
Time
13:00 - 14:00
Proffered Paper session 1 (ID 12)
Q&A and discussion (ID 309)
Lecture Time
15:05 - 15:15
Speakers
Authors
Session Name
Room
Munich Hall
Date
Tue, 03.05.2022
Time
13:45 - 15:15